These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32209402)

  • 61. Genotype-related differences of hippocampal apolipoprotein E levels only in early stages of neuropathological changes in Alzheimer's disease.
    Glöckner F; Meske V; Ohm TG
    Neuroscience; 2002; 114(4):1103-14. PubMed ID: 12379263
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Genetics of Alzheimer's disease: an insight into presenilins and apolipoprotein E instigated neurodegeneration.
    Obulesu M; Somashekhar R; Venu R
    Int J Neurosci; 2011 May; 121(5):229-36. PubMed ID: 21545304
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Apolipoprotein E4 and Alzheimer's disease].
    Mori S
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():812-7. PubMed ID: 11347179
    [No Abstract]   [Full Text] [Related]  

  • 64. Epidemiological, clinical, and neuropathological study of apolipoprotein E genotype in Alzheimer's disease.
    Hyman BT; Gomez-Isla T; Rebeck GW; Briggs M; Chung H; West HL; Greenberg S; Mui S; Nichols S; Wallace R; Growdon JH
    Ann N Y Acad Sci; 1996 Dec; 802():1-5. PubMed ID: 8993478
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Apolipoprotein E and the neuropathology of Alzheimer's disease.
    Mirra SS
    Hum Pathol; 1999 Oct; 30(10):1125-7. PubMed ID: 10534156
    [No Abstract]   [Full Text] [Related]  

  • 66. Rare APOE Missense Variants-Can We Overcome APOE ε4 and Alzheimer Disease Risk?
    Rabinovici GD; Dubal DB
    JAMA Neurol; 2022 Jul; 79(7):649-651. PubMed ID: 35639398
    [No Abstract]   [Full Text] [Related]  

  • 67. Head injury and risk of Alzheimer's disease by apolipoprotein E genotype.
    O'Meara ES; Kukull WA; Sheppard L; Bowen JD; McCormick WC; Teri L; Pfanschmidt M; Thompson JD; Schellenberg GD; Larson EB
    Am J Epidemiol; 1997 Sep; 146(5):373-84. PubMed ID: 9290497
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Characterization of APOE Christchurch carriers in 455,306 UK Biobank participants.
    He KY; Khramtsova EA; Cabrera-Socorro A; Zhang Y; Li S; Sarver BAJ; Smets B; Li QS; De Muynck L; Parrado AR; Lovestone S; Black MH
    Mol Neurodegener; 2023 Nov; 18(1):92. PubMed ID: 38017580
    [No Abstract]   [Full Text] [Related]  

  • 69. Cognitive impairment in Alzheimer's disease is modified by APOE genotype.
    van der Vlies AE; Pijnenburg YA; Koene T; Klein M; Kok A; Scheltens P; van der Flier WM
    Dement Geriatr Cogn Disord; 2007; 24(2):98-103. PubMed ID: 17596691
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The use of apolipoprotein E genotyping as a diagnostic test in suspected Alzheimer's disease.
    van Gool WA
    Ann N Y Acad Sci; 1996 Dec; 802():79-91. PubMed ID: 8993487
    [No Abstract]   [Full Text] [Related]  

  • 71. ApoE: new risk factor for Alzheimer's.
    Butler RN
    Geriatrics; 1994 Aug; 49(8):10-1. PubMed ID: 8039724
    [No Abstract]   [Full Text] [Related]  

  • 72. Apolipoprotein E genotype is not associated with cognitive impairment in older adults with bipolar disorder.
    Kerr DS; Stella F; Radanovic M; Aprahamian I; Bertollucci PH; Forlenza OV
    Bipolar Disord; 2016 Feb; 18(1):71-7. PubMed ID: 26877211
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The interaction of amyloid-beta with ApoE.
    Carter DB
    Subcell Biochem; 2005; 38():255-72. PubMed ID: 15709483
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Influence of the apolipoprotein E type 4 allele on cerebral glucose metabolism in Alzheimer's disease patients.
    Lee KU; Lee JS; Kim KW; Jhoo JH; Lee DY; Yoon JC; Lee JH; Lee DS; Lee MC; Woo JI
    J Neuropsychiatry Clin Neurosci; 2003; 15(1):78-83. PubMed ID: 12556576
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Oxidative protein damage in cells engaged in beta-amyloidosis is related to apoE genotype.
    Mazur-Kolecka B; Frackowiak J; Kowal D; Krzeslowska J; Dickson D
    Neuroreport; 2002 Mar; 13(4):465-8. PubMed ID: 11930162
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The effect of APOE genotype on clinical phenotype in Alzheimer disease.
    Borroni B; Di Luca M; Padovani A
    Neurology; 2007 Feb; 68(8):624; author reply 624. PubMed ID: 17310043
    [No Abstract]   [Full Text] [Related]  

  • 77. Reduced cholinergic function in normal and Alzheimer's disease brain is associated with apolipoprotein E4 genotype.
    Allen SJ; MacGowan SH; Tyler S; Wilcock GK; Robertson AG; Holden PH; Smith SK; Dawbarn D
    Neurosci Lett; 1997 Dec; 239(1):33-6. PubMed ID: 9547165
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Genes implicated in the pathogenesis of Alzheimer's disease.
    Das HK; Lal H
    Front Biosci; 1997 Jun; 2():d253-9. PubMed ID: 9206974
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Alzheimer's disease: treatment research finds new targets.
    Hodes RJ
    J Am Geriatr Soc; 1994 Jun; 42(6):679-81. PubMed ID: 8201156
    [No Abstract]   [Full Text] [Related]  

  • 80. APOE genotype predicts when--not whether--one is predisposed to develop Alzheimer disease.
    Meyer MR; Tschanz JT; Norton MC; Welsh-Bohmer KA; Steffens DC; Wyse BW; Breitner JC
    Nat Genet; 1998 Aug; 19(4):321-2. PubMed ID: 9697689
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.